New York, NY, Aug. 16, 2023 (GLOBE NEWSWIRE) -- Polaris Market Research has published a new research report titled “Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2’FL, 3’FL, 3’SL, 6’SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032” in its research database.
“As per the latest research analysis, the global human milk oligosaccharides (HMO) market size/share will be valued at roughly USD 231.86 Million in 2022, and its revenue is projected to reach about USD 1,799.96 Million By 2032. The market is forecasted to expand at a compound annual growth rate of approximately 22.8% between 2023 and 2032.”
What is Human Milk Oligosaccharides (HMO)? How Big is Human Milk Oligosaccharides (HMO) Market Size & Share?
- Overview
Breast milk is crucial for infants as it offers nutrients and immunological compounds. Amidst these compounds, human milk oligosaccharides constitute breast milk's third most crucial element after lipids and lactose. The rapidly rising demand for the human milk oligosaccharides (HMO) market can be attributed to the fact that they instigate bacterial colonization in the intestinal tract, which is favorable for health.
Altering consumer lifestyles and their escalating worries in the context of health and wellness are some of the other eminent factors pushing the demand for HMOs globally. They are effective food and beverage commodities, and food options can assist in the cure of specific illnesses and escalated probability, which is expected to boost product demand.
Request Sample Copy of Human Milk Oligosaccharides (HMO) Market Research Report @ https://polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-sample
(The sample of this report is readily available on request. The report sample contains a brief introduction to the research report, a Table of Contents, a Graphical introduction of regional analysis, Top players in the market with their revenue analysis, and our research methodology.)
Our Sample Report Covers:
- 2032 Updated Report Introduction, Overview, and In-depth industry analysis.
- 110+ Pages Research Report (Inclusion of Updated Research).
- Provide Chapter-wise guidance on Requests.
- 2023 Updated Regional Analysis with Graphical Representation of Size, Share & Trends
- Includes Updated List of tables & figures.
- Updated Report Includes Top Market Players with their Business Strategy, Sales Volume, and Revenue Analysis.
Some of the Top Market Leaders Are:
- Elicityl S.A.
- Abbott Laboratories
- Biosynth Carbosynth
- Dextra Laboratories Ltd.
- Dupont Nutrition & Biosciences
- Glycosyn
- BASF S.E.
- Glycom A/S
- Nestle Health Science
- Neolacta Lifesciences Pvt. Ltd
- Royal DSM
- Medolac Laboratories
- Chr. Hansen Holding A/S
- ZuChem
- Inbiose NV
- Royal FrieslandCampina N.V
To Know Additional List of Key Players, Request Here to Download a Free Report PDF Brochure: https://polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-sample
OR
Directly Purchase a copy of the report with TOC @ https://polarismarketresearch.com/buy/1379/2
Human Milk Oligosaccharides (HMO) Market: Report Scope
| Report Attribute | Details |
| Revenue Forecast in 2032 | USD 1,799.96 Million |
| Market size value in 2023 | USD 283.66 Million |
| Expected CAGR Growth | 22.8% from 2023 – 2032 |
| Base Year | 2022 |
| Forecast Year | 2023 – 2032 |
| Top Market Players | Elicityl S.A., Abbott Laboratories, Biosynth Carbosynth, Dextra Laboratories Ltd., Dupont Nutrition & Biosciences, Glycosyn, BASF S.E., Glycom A/S, Nestle Health Science, Neolacta Lifesciences Pvt. Ltd, Royal DSM, Medolac Laboratories, Chr. Hansen Holding A/S, ZuChem, Inbiose NV, and Royal FrieslandCampina N.V. |
| Segments Covered | By Type, By Application, By Distribution Channel, By Region |
| Customization Options | Customized purchase options are available to meet any research needs. Explore customized purchase options |
Prominent Growth Driving Factors
- Escalation in infant population: As the worldwide population persists to evolve, so does the number of infants. The human milk oligosaccharides (HMO) market size is expanding as the escalation in the infant population head-on renders an escalated demand for infant nutrition commodities, including infant formulae and dietary supplements.
- Dietary additives: The growth in demand for dietary additives and escalating consciousness among consumers about the significance of gut health are anticipated to push the market growth. They work as prebiotics in the human body and are important in sustaining gut health. The human milk oligosaccharides (HMO) market sales are soaring as they smoothen the development path of beneficial bacteria, especially bifidobacteria, in the gut, causing enhanced metabolic activity.
- Brain development: HMOs are essentially accountable for prohibiting infection, offering sialic acid for brain development, and displaying prebiotic results. But, oligosaccharide congregation in bovine milk-derived infant formulae is lesser when juxtaposed to human milk-derived formulae.
Request for a Discount on this Report Before Purchase @ https://polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/request-for-discount-pricing
Top Findings of the Report
- HMOs are essentially accountable for prohibiting infection, offering sialic acid for brain development, and displaying prebiotic results.
- The human milk oligosaccharides (HMO) market segmentation is primarily based on type, application, distribution channel, and region.
- Asia Pacific region is expected to grow speedily during the forecast period.
Top Trends Influencing the Market
- Enhance immune function: The market for HMOs has gained notable awareness and development in recent years because of their capable health advantages and the growing demand for fitter infant nutrition options. They offer several benefits, such as immune function, lessening infection probability, enhancing cognitive advancement, and encouraging gastrointestinal health in infants.
- Escalating birth rates: The market is also driven by growing consciousness about the significance of breastfeeding and the advantages of HMOs, growing birth rates, and escalating disposable incomes in emerging regions. Further, progression in technology and research has sanctioned the production of HMOs through fermentation procedures, aiding the human milk oligosaccharides (HMO) market growth.
- Acting as prebiotics: HMOs are organically transpiring prebiotics profusely instituted in breast milk following carbohydrates and fats. They impact the microbiome and provide for breastfed babies' immune systems. They perform as prebiotics, reinforcing the development of beneficial bacteria.
Segmental Analysis
- The Infant Formula Segment Accounted for the Largest Market Share
Based on application, the infant formula segment accounted for the largest market share. The human milk oligosaccharides (HMO) market demand is on the rise due to the increasing demand for HMOs in the advancement of infant formulae as HMOs provide advantageous features that assist in safeguarding infants from infections, improvise their memory, encourage prebiotics effects, reinforce brain development and sustain gut health.
- Drug Store or Pharmacy Segment Dominated the Market
Based on distribution channels, the drugstore or pharmacy segment dominated the market. The human milk oligosaccharides (HMO) market trends include the fact that these establishments have a deep-rooted existence of a broad gamut of stores rendering them simply obtainable to consumers. This obtainability element is important in captivating customers who look for ease and choose to buy healthcare commodities from nearby locations.
Inquire more about this report before purchase @ https://polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market/inquire-before-buying
(Inquire about a report quote OR available discount offers to the sales team before purchase.)
The market is primarily segmented based on type, application, distribution channel, and region.
| By Type | By Application | By Distribution Channel | By Region |
|
|
|
|
Geographical Overview
Asia Pacific: This region held the largest human milk oligosaccharides (HMO) market share due to its extensive consumer base and growing infant population. The development is propelled by the region's impact on the infant formulae market, where HMOs are important components in formulating infant food and supplements.
Browse the Detail Report “Human Milk Oligosaccharides (HMO) Market Share, Size, Trends, Industry Analysis Report, By Type (2’FL, 3’FL, 3’SL, 6’SL); By Application; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032” with in-depth TOC: https://polarismarketresearch.com/industry-analysis/human-milk-oligosaccharides-hmo-market
For Additional Information OR Media Enquiry, Please Mail At: sales@polarismarketresearch.com
Recent Developments
- In June 2021, H&H Group, an Australian company, introduced a new kids' supplement named ProBOOST + Vit D under Biostime. This innovative product contains Human Milk Oligosaccharides (HMOs) and is specifically formulated for children aged 12 months and above. This launch highlights H&H Group's commitment to providing high-quality nutritional supplements that incorporate HMOs to support the health and development of children.
- In April 2020, the company Kyowa Hakko, which specializes in health products, expanded its production capabilities for HMOs in Thailand. This strategic move was driven by the anticipated global increase in the market for these health products in the upcoming years.
The Report Answers Questions Such As
- What are the key segments in the market?
- How much is the market worth?
- At what CAGR is the market predicted to grow during the forecast period?
- Which region is leading the market?
- What are the key driving factors in the market?
- What are the upcoming opportunities and trends in the HMO market?
Polaris Market Research has segmented the human milk oligosaccharides (HMO) market report based on type, application, distribution channel, and region:
By Type Outlook
- 2’FL
- 3’FL
- 3’SL
- 6’SL
By Application Outlook
- Infant Formula
- Functional Food & Beverage
- Food Supplements
By Distribution Channel Outlook
- Hypermarkets & Supermarkets
- Drug Store or Pharmacy
- Online Sales Channel
- Others
By Region Outlook
- North America (U.S., Canada)
- Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
- Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
- Latin America (Brazil, Mexico, Argentina)
- Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
About Polaris Market Research:
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.
Contact:
Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Blog: https://polarismarketresearch.medium.com | https://polarisnewsblog.com
